OBJECTIVES Eevaluate the clinical outcomes of a pharmacist-conducted MTMP for Lucas County employees and their dependents with diabetes and/or hypertension over a one year period. METHODS A retrospective-prospective study using a cohort receiving pharmacist provided MTM services in Northwest Ohio was used. Services were provided to eligible Lucas County employees by a coalition of independent pharmacies. Subjects eligible to participate must have had primary medical insurance and prescription coverage through Lucas County and should have a diagnosis of diabetes and hypertension. Data was extracted from the pharmacists' intake forms and clinical notes. Clinical outcomes extracted were A1c, systolic blood pressure (SBP), diastolic blood pressure (DBP), and body mass index (BMI). Patient's self-monitored blood glucose (SMBG) and caffeine intake per day were also documented. The patients considered for analyses had at least two documented visits at one of the coalition pharmacies within one year of their enrollment. Wilcoxon signed-rank test was used to analyze data. RESULTS A total of 467 patients have been enrolled to date. Of these, 193 patients have documented baseline A1c values. For A1c, patients with values greater than 7 at baseline were considered for data analyses (N=70). Within one year of starting the MTM program, these patients' mean A1c values decreased from 8.21 to 7.41 (P=0.000). Three hundred and fifty three patients have documented baseline blood pressure values. Within 1 year, the SBP decreased from 130.72 to 127.84 (P=0.006) and DBP decreased from 81.75 to 80.03 (P=0.004) (N=319). Similarly, BMI has decreased non-significantly, caffeine consumption has decreased significantly (P<0.05) (N=143) and SMBG per day has also increased significantly (P<0.05) (N=82). CONCLUSIONS This study provides an initial glimpse into the impact of pharmacists' interventions on clinical outcomes for patients participating in an employer-sponsored MTMP.